Salutech

 Current Startup

SaluTech has developed a patent-pending conductive biomaterial (CBM) to reduce Atrial Fibrillation by resynchronizing the erratic electrical signals in the atria. CBM is a non-toxic, long-lasting, and biocompatible nano-membrane that mimics the velocity of healthy heart tissue.

  • Tags: Biotech